AU2003303051A1 - Cell death inhibitor - Google Patents

Cell death inhibitor

Info

Publication number
AU2003303051A1
AU2003303051A1 AU2003303051A AU2003303051A AU2003303051A1 AU 2003303051 A1 AU2003303051 A1 AU 2003303051A1 AU 2003303051 A AU2003303051 A AU 2003303051A AU 2003303051 A AU2003303051 A AU 2003303051A AU 2003303051 A1 AU2003303051 A1 AU 2003303051A1
Authority
AU
Australia
Prior art keywords
cell death
death inhibitor
inhibitor
cell
death
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303051A
Other versions
AU2003303051A8 (en
Inventor
Hiroaki Hirata
Masaji Matsunaga
Hirokazu Otaki
Seiji Shioda
Atsushi Takaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Nissei Bio Co Ltd
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of AU2003303051A8 publication Critical patent/AU2003303051A8/en
Publication of AU2003303051A1 publication Critical patent/AU2003303051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003303051A 2002-12-18 2003-12-02 Cell death inhibitor Abandoned AU2003303051A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002366637A JP2004196701A (en) 2002-12-18 2002-12-18 Cell death inhibitor
JP2002-366637 2002-12-18
PCT/JP2003/015412 WO2004054594A1 (en) 2002-12-18 2003-12-02 Cell death inhibitor

Publications (2)

Publication Number Publication Date
AU2003303051A8 AU2003303051A8 (en) 2004-07-09
AU2003303051A1 true AU2003303051A1 (en) 2004-07-09

Family

ID=32588319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303051A Abandoned AU2003303051A1 (en) 2002-12-18 2003-12-02 Cell death inhibitor

Country Status (3)

Country Link
JP (1) JP2004196701A (en)
AU (1) AU2003303051A1 (en)
WO (1) WO2004054594A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007117014A (en) * 2005-10-28 2007-05-17 Nissan Chem Ind Ltd Nutritive supplement for preventing rheumatoid arthritis
JP5820127B2 (en) * 2011-02-17 2015-11-24 フォーデイズ株式会社 Preventive / ameliorating agent for neurodegenerative diseases with amyloid fibril formation
US9896488B2 (en) 2013-06-18 2018-02-20 University Of Helsinki Protamine in treatment of neuronal injuries
KR20170001567A (en) * 2015-06-26 2017-01-04 주식회사 파마리서치프로덕트 Composition comprising mixture of DNA fragments separated from fish's semen or testis for the prevention or treatment of ischemic colitis
KR102234367B1 (en) * 2020-09-07 2021-03-31 바이오메디팜 어업회사법인 주식회사 Extraction Method of high purity Poly Deoxy Ribo Nucleotide from testicular and sperm of Salmonid fish

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH062677B2 (en) * 1984-05-26 1994-01-12 日産化学工業株式会社 Hematopoietic organ recovery promoter
JPH0669953B2 (en) * 1985-08-16 1994-09-07 日産化学工業株式会社 Cerebrospinal system neurotrophic agent
JPH0551325A (en) * 1991-04-19 1993-03-02 Morinaga Milk Ind Co Ltd Agent for promoting production of nerve growth factor
JPH08187059A (en) * 1994-06-06 1996-07-23 J One Prod Kk Production of food of nucleic acid
JPH08165246A (en) * 1994-12-10 1996-06-25 Nisshoku Corp Physiological activity promoter and physiological activity promotive encapsulating agent
JPH10218781A (en) * 1997-02-04 1998-08-18 Nisshin Oil Mills Ltd:The Regulator for physical condition
JPH10215828A (en) * 1997-02-04 1998-08-18 Nisshin Oil Mills Ltd:The Active oxygen seed elimination agent
JP2000169386A (en) * 1998-12-10 2000-06-20 Sarude Yakuhin Kk Immune function-activating agent, and beverage or food therefor
JP2001061484A (en) * 1999-06-23 2001-03-13 Sankyo Co Ltd Polynucleotide with anti-apoptotic activity
MXPA02001479A (en) * 1999-08-12 2003-07-21 Asafov Alexndr Vilenovich Blood plasma replacement solution.
JP3682241B2 (en) * 2001-05-25 2005-08-10 Ｙｋｋ Ａｐ株式会社 Sash performance prediction method and sash performance prediction program
JP2003235504A (en) * 2002-02-13 2003-08-26 Marino Forum 21 Endurance-building drug
JP3713553B2 (en) * 2002-05-15 2005-11-09 福美 森重 Cerebrospinal neurotrophic agent containing arginine and RNA

Also Published As

Publication number Publication date
JP2004196701A (en) 2004-07-15
AU2003303051A8 (en) 2004-07-09
WO2004054594A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003239909A1 (en) Enhanced-service provision
AU2003303483A1 (en) Ccr8 inhibitors
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003902946A0 (en) Dpp-iv inhibitor
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003900608A0 (en) Hdac inhibitor
AU2003902260A0 (en) Dpp-iv inhibitor
AU2003249683A1 (en) Nf-:b inhibitors
AU2003289386A1 (en) Jnk inhibitors
AU2003255952A1 (en) Oxytocin inhibitors
AU2002952946A0 (en) Dpp-iv inhibitor
AU2003233426A1 (en) Corrosion inhibitor
AU2003244750A1 (en) Polymerisation inhibitor
AU2003289287A1 (en) Jnk inhibitor
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003263502A1 (en) Storage
AU2003271196A1 (en) Spanner
AU2003235122A1 (en) Cell death inhibitor
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003244778A1 (en) Firelighters
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2003277444A1 (en) Two-way ranging techniques
AU2003303051A1 (en) Cell death inhibitor

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 32, PAGE(S) 8415 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME NISSAN CHEMICAL INDUSTRIES, LTD., APPLICATION NO. 2003303051, UNDER INID (71) CORRECT THE NAME TO READ NISSAN CHEMICAL INDUSTRIES, LTD.; NISSEI BIO CO., LTD.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase